€63.00
1.86% yesterday
Madrid, Nov 22, 05:35 pm CET
ISIN
ES0157261019
Symbol
ROVI
Index
Sector
Industry

Laboratorios Farmaceuticos Stock price

€63.00
-13.85 18.02% 1M
-25.85 29.09% 6M
+2.80 4.65% YTD
+10.40 19.77% 1Y
+1.50 2.44% 3Y
+39.00 162.50% 5Y
+54.07 605.49% 10Y
Madrid, Closing price Fri, Nov 22 2024
+1.15 1.86%
ISIN
ES0157261019
Symbol
ROVI
Index
Sector
Industry

Key metrics

Market capitalization €3.19b
Enterprise Value €3.31b
P/E (TTM) P/E ratio 19.56
EV/FCF (TTM) EV/FCF 54.73
EV/Sales (TTM) EV/Sales 3.99
P/S ratio (TTM) P/S ratio 3.85
P/B ratio (TTM) P/B ratio 5.82
Dividend yield 1.75%
Last dividend (FY24) €1.10
Revenue growth (TTM) Revenue growth 1.44%
Revenue (TTM) Revenue €829.51m
EBIT (operating result TTM) EBIT €219.47m
Free Cash Flow (TTM) Free Cash Flow €60.55m
Cash position €17.55m
EPS (TTM) EPS €3.22
P/E forward 20.02
P/S forward 4.02
EV/Sales forward 4.17
Show more

Is Laboratorios Farmaceuticos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Laboratorios Farmaceuticos Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Laboratorios Farmaceuticos forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Laboratorios Farmaceuticos forecast:

Buy
100%

Financial data from Laboratorios Farmaceuticos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '23
+/-
%
830 830
1% 1%
100%
- Direct Costs 363 363
13% 13%
44%
466 466
6% 6%
56%
- Selling and Administrative Expenses 197 197
1% 1%
24%
- Research and Development Expense 25 25
4% 4%
3%
244 244
12% 12%
29%
- Depreciation and Amortization 24 24
6% 6%
3%
EBIT (Operating Income) EBIT 219 219
14% 14%
26%
Net Profit 170 170
15% 15%
21%

In millions EUR.

Don't miss a Thing! We will send you all news about Laboratorios Farmaceuticos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.

Head office Spain
CEO Juan Encina
Employees 2,111
Founded 1946
Website www.rovi.es

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today